ARTICLE | Distillery Therapeutics
Cardiovascular
December 19, 2017 8:54 PM UTC
Mouse studies suggest inhibiting CDKN1A could help treat cardiac injury. In cardiac tissue from a neonatal mouse model of surgical resection-induced cardiac injury, levels of CDKN1A were lower in the ...
BCIQ Company Profiles
BCIQ Target Profiles
Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) (CIP1)